An Agent-based Model for Investigating the Effect of Myeloid-Derived Suppressor Cells and its Depletion on Tumor Immune Surveillance
DOI: 10.4103/jmss.JMSS_33_18
Abstract
Purpose: To predict the behavior of biological systems, mathematical models of biological systems have been shown to be useful. In particular, mathematical models of tumor-immune system interactions have demonstrated promising results in prediction of different behaviors of tumor against the immune system. Materials and Methods: This study aimed at the introduction of a new model of tumor-immune system interaction, which includes tumor and immune cells as well as myeloid-derived suppressor cells (MDSCs). MDSCs are immune suppressor cells that help the tumor cells to escape the immune system. The structure of this model is agent-based which makes possible to investigate each component as a separate agent. Moreover, in this model, the effect of low dose 5-fluorouracil (5-FU) on MDSCs depletion was considered. Results: Based on the findings of this study, MDSCs had suppressive effect on increment of immune cell number which consequently result in tumor cells escape the immune cells. It has also been demonstrated that low-dose 5-FU could help immune system eliminate the tumor cells through MDSCs depletion. Conclusions: Using this new agent-based model, multiple injection of low-dose 5-FU could eliminate MDSCs and therefore might have the potential to be considered in treatment of cancers.
Keywords
Full Text:
PDFReferences
Corthay A. Does the immune system naturally protect against cancer? Front Immunol 2014;5:197.
Burnet M. Cancer; a biological approach. I. The processes of control. Br Med J 1957;1:779-86.
Burnet FM. Immunological aspects of malignant disease. Lancet 1967;1:1171-4.
Pourhasanzade F, Sabzpoushan SH, Alizadeh AM, Esmati E. An agent-based model of avascular tumor growth: Immune response tendency to prevent cancer development. Simulation 2017;93:641-57.
Jafari AH, Hadjati J, Allahverdy A, Zandi S, Mirzaei HR, Rahbar S, et al. A predictive approach for the tumor-immune system interactions based on an agent based modeling. Front Biomed Technol 2017;2:214-26.
Smyth MJ, Thia KY, Street SE, MacGregor D, Godfrey DI, Trapani JA. Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J Exp Med 2000;192:755-60.
Kim R, Emi M, Tanabe K. Cancer immunoediting from immune surveillance to immune escape. Immunology 2007;121:1-4.
Murphy K, Travers P, Walport M and Janeway C. Immunobiology. 7th. New York: Garland Science. 2008.
Vincent J, Mignot G, Chalmin F, Ladoire S, Bruchard M, Chevriaux A, et al. 5-fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity. Cancer Res 2010;70:3052-61.
Kusmartsev S, Cheng F, Yu B, Nefedova Y, Sotomayor E, Lush R, et al. All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination. Cancer Res 2003;63:4441-9.
Ishizaki H, Manuel ER, Song GY, Srivastava T, Sun S, Diamond DJ, et al. Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model. Cancer Immunol Immunother 2011;60:99-109.
Weiss T, Vitacolonna M, Zöller M. The efficacy of an IL-1alpha vaccine depends on IL-1RI availability and concomitant myeloid-derived suppressor cell reduction. J Immunother 2009;32:552-64.
De Santo C, Serafini P, Marigo I, Dolcetti L, Bolla M, Del Soldato P, et al. Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination. Proc Natl Acad Sci U S A 2005;102:4185-90.
Tseng CW, Hung CF, Alvarez RD, Trimble C, Huh WK, Kim D, et al. Pretreatment with cisplatin enhances E7-specific CD8+ T-cell-mediated antitumor immunity induced by DNA vaccination. Clin Cancer Res 2008;14:3185-92.
Wesolowski R, Markowitz J, Carson WE 3rd. Myeloid derived suppressor cells – A new therapeutic target in the treatment of cancer. J Immunother Cancer 2013;1:10.
Araujo RP, McElwain DL. A history of the study of solid tumour growth: The contribution of mathematical modelling. Bull Math Biol 2004;66:1039-91.
Roose T, Chapman SJ, Maini PK. Mathematical models of avascular tumor growth. SIAM Rev 2007;49:179-208.
Martins M, Ferreira S, Vilela M. Multiscale models for the growth of avascular tumors. Phys Life Rev 2007;4:128-56.
Mazdeyasna S, Jafari AH, Hadjati J, Allahverdy A, Moghaddam MA. Modeling the effect of chemotherapy on melanoma B16F10 in mice using cellular automata and genetic algorithm in tapered dosage of fbs and cisplatin. Front Biomed Technol 2015;2:414-20.
d'Onofrio A. Metamodeling tumor-immune system interaction, tumor evasion and immunotherapy. Mathc Comput Model 2008;47:614-37.
Eftimie R, Bramson JL, Earn DJ. Interactions between the immune system and cancer: A brief review of non-spatial mathematical models. Bull Math Biol 2011;73:2-32.
Kuznetsov VA, Makalkin IA, Taylor MA, Perelson AS. Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis. Bull Math Biol 1994;56:295-321.
d'Onofrio A, Ciancio A. Simple biophysical model of tumor evasion from immune system control. Phys Rev E Stat Nonlin Soft Matter Phys 2011;84:031910.
Arciero J, Jackson T, Kirschner D. A mathematical model of tumor-immune evasion and siRNA treatment. Discrete Continuous Dyn Syst Ser B 2004;4:39-58.
Wilson S, Levy D. A mathematical model of the enhancement of tumor vaccine efficacy by immunotherapy. Bull Math Biol 2012;74:1485-500.
Kirschner D, Panetta JC. Modeling immunotherapy of the tumor-immune interaction. J Math Biol 1998;37:235-52.
d'Onofrio A, Ledzewicz U, Maurer H, Schättler H. On optimal delivery of combination therapy for tumors. Math Biosci 2009;222:13-26.
d'Onofrio A. A general framework for modeling tumor-immune system competition and immunotherapy: Mathematical analysis and biomedical inferences. Phys D 2005;208:220-35.
Allahverdy A, Rahbar S, Mirzaei RR, Ajami M, Namdar A, Habibi S, et al. Extracting mutual interaction rules using fuzzy structured agent-based model of tumor-immune system interactions. J Biomed Phys Eng 2016.
Dwek MR, Rixon L, Hurt C, Simon A, Newman S. Is there a relationship between objectively measured cognitive changes in patients with solid tumours undergoing chemotherapy treatment and their health-related quality of life outcomes? A systematic review. Psychooncology 2017;26:1422-32.
Andersson KM, Dahlgren CV, Reizenstein J, Cao Y, Ahnesjö A, Thunberg P. CT Image Metal Artifacts in Proton Radiotherapy Treatment Planning: Evaluation of Two Commercial Correction Algorithms; 2018.
Hatzikirou H, López Alfonso JC, Leschner S, Weiss S, Meyer-Hermann M. Therapeutic potential of bacteria against solid tumors. Cancer Res 2017;77:1553-63.
Hatzikirou H, Alfonso JC, Mühle S, Stern C, Weiss S, Meyer-Hermann M. Cancer therapeutic potential of combinatorial immuno- and vasomodulatory interventions. J R Soc Interface 2015;12. pii: 20150439.
Banchereau J, Palucka K. Immunotherapy: Cancer vaccines on the move. Nat Rev Clin Oncol 2018;15:9-10.
Namdar A, Mirzaei HR, Jadidi-Niaragh F, Ashourpour M, Ajami M, Hadjati J, et al. Multiple low doses of 5-fluorouracil diminishes immunosuppression by myeloid derived suppressor cells in murine melanoma model. Iran J Immunol 2015;12:176-87.
Figueredo GP, Siebers PO, Aickelin U. Investigating mathematical models of immuno-interactions with early-stage cancer under an agent-based modelling perspective. BMC Bioinformatics 2013;14 Suppl 6:S6.
Figueredo GP, Siebers PO, Owen MR, Reps J, Aickelin U. Comparing stochastic differential equations and agent-based modelling and simulation for early-stage cancer. PLoS One 2014;9:e95150.
Umansky V, Sevko A, Gebhardt C, Utikal J. Myeloid-derived suppressor cells in malignant melanoma. J Dtsch Dermatol Ges 2014;12:1021-7.
Nagaraj S, Gabrilovich DI. Tumor escape mechanism governed by myeloid-derived suppressor cells. Cancer Res 2008;68:2561-3.
Busch K, Klapproth K, Barile M, Flossdorf M, Holland-Letz T, Schlenner SM, et al. Fundamental properties of unperturbed haematopoiesis from stem cells in vivo. Nature 2015;518:542-6.
Refbacks
- There are currently no refbacks.
https://e-rasaneh.ir/Certificate/22728
ISSN : 2228-7477